logo
logo
Nature's Sunshine Products, Inc.

Nature's Sunshine Products, Inc.

NASDAQ•NATR
CEO: Mr. Terrence O. Moorehead
セクター: Consumer Defensive
業種: Packaged Foods
上場日: 2009-06-25
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
連絡先情報
2901 West Bluegrass Boulevard, Suite 100, Lehi, UT, 84043, United States
801-341-7900
www.naturessunshine.com
時価総額
$470.81M
PER (TTM)
31.4
11.5
配当利回り
--
52週高値
$27.04
52週安値
$11.01
52週レンジ
99%
順位26Top 13.0%
5.5
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
堅調 • 5.5 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

財務ダッシュボード

Q3 2025 データ

売上高

$128.34M+11.97%
直近4四半期の推移

EPS

$0.30+30.44%
直近4四半期の推移

フリーCF

$16.79M+113.00%
直近4四半期の推移

2025 Q3 決算ハイライト

主なハイライト

Q3 Sales and Profit Growth Third quarter Net sales reached $128.3M, a 12.0% increase; Operating Income surged 69.9% to $9.0M.
Nine Month Net Income Jumps Nine-month Net Income attributable to common shareholders was $15.4M, reflecting an 84.8% increase over 2024.
Operating Cash Flow Doubles Net cash provided by operating activities was $25.4M for nine months, nearly doubling the $13.1M provided in 2024.
Balance Sheet Cash Position Cash and equivalents increased to $95.6M as of September 30, 2025, up from $84.7M at year-end 2024.

リスク要因

Trade Compliance Investigation Closed Filed final voluntary self-disclosures regarding apparent trade controls violations; outcome uncertainty remains regarding potential fines.
Eastern Europe Geopolitical Risk Sustained conflict in Eastern Europe continues to impact business operations and sales in the region for the foreseeable future.
Tariff Cost Pressure Monitoring Monitoring potential material cost increases from tariffs on raw materials; full-year impact is not expected to be material.
Rising Current Liabilities Total current liabilities increased to $83.6M by September 30, 2025, driven by higher accrued liabilities and incentives.

見通し

China JV Full Ownership Agreements finalized to purchase remaining interests in two China joint ventures for $7.0M cash consideration by year-end.
Share Repurchase Program Active Repurchased $14.4M in common stock during nine months; $19.3M remains available under the authorized program.
International Sales Reliance International operations remain a significant sales driver, though results are subject to foreign currency exchange rate fluctuations.
Tax Disclosure Standard Adoption Adoption of ASU 2023-09 regarding income tax disclosures is effective December 15, 2024, with no expected material impact.

同業比較

売上高 (TTM)

B&G Foods, Inc.BGS
$1.84B
-6.0%
USANA Health Sciences, Inc.USNA
$912.67M
+5.9%
Nature's Sunshine Products, Inc.NATR
$474.54M
+6.6%

粗利益率 (最新四半期)

USANA Health Sciences, Inc.USNA
73.4%
-5.2pp
Nature's Sunshine Products, Inc.NATR
73.3%
+1.9pp
European Wax Center, Inc.EWCZ
64.0%
-9.0pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
NATR$470.81M31.49.5%5.4%
BGS$418.28M-1.7-49.8%70.4%
WILC$402.03M13.118.5%0.7%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
2.8%
緩やかな成長
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
100%
優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年3月9日
|
EPS:-
|
売上高:-
財務レポート
財務データ
全年度

  • Form 10-Q - Q3 2025

    会計期末: 2025年9月30日|提出日: 2025年11月6日|
    売上高: $128.34M+12.0%
    |
    EPS: $0.30+30.4%
    予想を上回る

  • Form 10-Q - Q2 2025

    会計期末: 2025年6月30日|提出日: 2025年7月31日|
    売上高: $114.75M+3.8%
    |
    EPS: $0.29+314.3%
    予想を上回る

  • Form 10-Q - Q1 2025

    会計期末: 2025年3月31日|提出日: 2025年5月6日|
    売上高: $113.25M+2.0%
    |
    EPS: $0.26+116.7%
    予想を上回る

  • Form 10-K - FY 2024

    会計期末: 2024年12月31日|提出日: 2025年3月11日|
    売上高: $454.36M+2.0%
    |
    EPS: $0.41-48.1%
    予想を上回る

  • Form 10-Q - Q3 2024

    会計期末: 2024年9月30日|提出日: 2024年11月7日|
    売上高: $114.62M+3.1%
    |
    EPS: $0.23+53.3%
    予想を上回る

  • Form 10-Q - Q2 2024

    会計期末: 2024年6月30日|提出日: 2024年8月8日|
    売上高: $110.55M-5.1%
    |
    EPS: $0.07-46.2%
    予想を下回る

  • Form 10-Q - Q1 2024

    会計期末: 2024年3月31日|提出日: 2024年5月7日|
    売上高: $110.99M+2.2%
    |
    EPS: $0.12+82.6%
    予想を下回る

  • Form 10-K - FY 2023

    会計期末: 2023年12月31日|提出日: 2024年3月12日|
    売上高: $445.32M+5.5%
    |
    EPS: $0.79+4050.0%
    予想を上回る